Full Name
Angela Liu Ming Lai
(not current staff)
Variants
Liu, A.M.
 
Main Affiliation
 
 
Email
csialml@nus.edu.sg
 

Publications

Refined By:
Department:  PHARMACOLOGY

Results 1-11 of 11 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
1Mar-2012An update on targeting Hippo-YAP signaling in liver cancerLiu, A.M. ; Xu, Z.; Luk, J.M.
210-Mar-2011AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinomaXu, M.Z.; Chan, S.W.; Liu, A.M. ; Wong, K.F. ; Fan, S.T.; Chen, J.; Poon, R.T.; Zender, L.; Lowe, S.W.; Hong, W.; Luk, J.M.
32-Sep-2011DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survivalLuk, J.M.; Burchard, J.; Zhang, C.; Liu, A.M. ; Wong, K.F. ; Shek, F.H.; Lee, N.P.; Fan, S.T.; Poon, R.T.; Ivanovska, I.; Philippar, U.; Cleary, M.A.; Buser, C.A.; Shaw, P.M.; Lee, C.-N.; Tenen, D.G.; Dai, H.; Mao, M.
416-Sep-2011Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinomaIvanovska, I.; Zhang, C.; Liu, A.M. ; Wong, K.F. ; Lee, N.P.; Lewis, P.; Philippar, U.; Bansal, D.; Buser, C.; Scott, M.; Mao, M.; Poon, R.T.P.; Fan, S.T.; Cleary, M.A.; Luk, J.M.; Dai, H.
52012Genome-wide survey of recurrent HBV integration in hepatocellular carcinomaSung, W.-K. ; Zheng, H.; Li, S.; Chen, R.; Liu, X.; Li, Y.; Lee, N.P.; Lee, W.H.; Ariyaratne, P.N.; Tennakoon, C.; Mulawadi, F.H.; Wong, K.F. ; Liu, A.M. ; Poon, R.T.; Fan, S.T.; Chan, K.L.; Gong, Z.; Hu, Y.; Lin, Z.; Wang, G.; Zhang, Q.; Barber, T.D.; Chou, W.-C.; Aggarwal, A.; Hao, K.; Zhou, W.; Zhang, C.; Hardwick, J.; Buser, C.; Xu, J.; Kan, Z.; Dai, H.; Mao, M.; Reinhard, C.; Wang, J.; Luk, J.M.
61-Mar-2011Global Regulation on microRNA in Hepatitis B Virus-Associated Hepatocellular CarcinomaLiu, A.M. ; Zhang, C.; Burchard, J.; Fan, S.T.; Wong, K.-F. ; Dai, H.; Poon, R.T.; Luk, J.M.
72010MicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinomaBurchard, J.; Zhang, C.; Liu, A.M. ; Poon, R.T.P.; Lee, N.P.Y.; Wong, K.-F. ; Sham, P.C.; Lam, B.Y.; Ferguson, M.D.; Tokiwa, G.; Smith, R.; Leeson, B.; Beard, R.; Lamb, J.R.; Lim, L.; Mao, M.; Dai, H.; Luk, J.M.
8Feb-2013Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinomaHuo, X.; Zhang, Q.; Liu, A.M. ; Tang, C.; Gong, Y.; Bian, J.; Luk, J.M.; Xu, Z.; Chen, J.
91-May-2011Proteomics of hepatocellular carcinoma in chinese patientsLuk, J.M.; Liu, A.M. 
10Dec-2012Regulators of mammalian Hippo pathway in cancerLiu, A.M. ; Wong, K.-F. ; Jiang, X.; Qiao, Y.; Luk, J.M.
1120-May-2011Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122Boutz, D.R.; Collins, P.J.; Suresh, U.; Lu, M.; Ramírez, C.M.; Fernández-Hernando, C.; Huang, Y.; Abreu, R.D.S.; Le, S.-Y.; Shapiro, B.A.; Liu, A.M. ; Luk, J.M.; Aldred, S.F.; Trinklein, N.D.; Marcotte, E.M.; Penalva, L.O.F.